NCT00241072View on ClinicalTrials.gov

Clinical Trial To Evaluate The Effect Of Valsartan On Insulin Sensitivity In Subjects With Impaired Glucose Tolerance

PHASE4CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

July 31, 2005

Study Completion Date

July 31, 2005

Conditions
HypertensionImpaired Glucose Tolerance
Interventions
DRUG

valsartan

24 WEEKS OF TREATMENT WITH VALSARTAN (80 MG - 320 MG)

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY